Optimer researches, develops and commercializes pharmaceutical products.
Business Model:
Revenue: $76.9M
Employees: 201-500
Optimer was acquired by
Cubist Pharmaceuticals.
The acquisition happend on 2013-07-30.
Details of the transaction were not public
Address: 101 Hudson St
City: Jersey City
State: NJ
Zip: 07302
Country: US
Optimer researches, develops and commercializes pharmaceutical products.
Contact Phone:
+16506187714
Contact Email:
Listed Exchange:
NASDAQ
IPO Date:
2/16/2007
Ticker Symbol:
OPTR
IPO Price:
$7/share
Amount Raised:
$49M
Opened: -/share
EBITDA | - |
Total Cash | - |
Total Debt | - |
Total Revenue | - |
Total Profit (Gross) | - |
PE Ratio | - |
Announced Date | Transaction | Number of Investors | Money Raised | Lead Investors | 12/2005 | Series D | 8 | $22.2M |
SB Life Science Strategic Global Investments Fubon Bank China Development Industrial Bank (CDIB) ProQuest Investments Lurie Investment Fund YFY Biotech Management Company BB Biotech Ventures SB Life Science Strategic Global Investments Fubon Bank China Development Industrial Bank (CDIB) ProQuest Investments Lurie Investment Fund YFY Biotech Management Company BB Biotech Ventures |
9/2001 | Series B | 2 | $32M |
China Development Industrial Bank (CDIB) ProQuest Investments China Development Industrial Bank (CDIB) ProQuest Investments |
2/2007 | IPO | $49M |
|
3/2005 | Series C | 1 | $12M |
Par Pharmaceuticals Par Pharmaceuticals Par Pharmaceuticals |
---|
Announced Date | Name | Price |
---|
|
Revenue: 0 - 100000 Employees: Industry: Software |
Details
|
|
Revenue: 0 - 100000 Employees: 51 - 500 Industry: Education |
Details
|
|
Revenue: 0 - 100000 Employees: 1 - 10 Industry: Blockchain |
Details
|
|
Revenue: 0 - 100000 Employees: 11 - 50 Industry: Industrial |
Details
|
|
Revenue: 0 - 100000 Employees: 1 - 10 Industry: Advertising |
Details
|